Manaksia Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 3, 2025, 9:21 pm

Competitors of Manaksia Ltd

All Competitor Stocks of Manaksia Ltd

Quarterly Result

Last Updated: August 1, 2025, 5:30 pm

Below is a detailed analysis of the quarterly data for Manaksia Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 173.00 Cr.. The value appears to be declining and may need further review. It has decreased from 269.00 Cr. (Mar 2025) to 173.00 Cr., marking a decrease of 96.00 Cr..
• For Expenses, as of Jun 2025, the value is 163.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 254.00 Cr. (Mar 2025) to 163.00 Cr., marking a decrease of 91.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 10.00 Cr.. The value appears to be declining and may need further review. It has decreased from 15.00 Cr. (Mar 2025) to 10.00 Cr., marking a decrease of 5.00 Cr..
• For OPM %, as of Jun 2025, the value is 6.00%. The value appears strong and on an upward trend. It has increased from 5.00% (Mar 2025) to 6.00%, marking an increase of 1.00%.
• For Other Income, as of Jun 2025, the value is 14.00 Cr.. The value appears strong and on an upward trend. It has increased from 6.00 Cr. (Mar 2025) to 14.00 Cr., marking an increase of 8.00 Cr..
• For Interest, as of Jun 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 22.00 Cr.. The value appears strong and on an upward trend. It has increased from 17.00 Cr. (Mar 2025) to 22.00 Cr., marking an increase of 5.00 Cr..
• For Tax %, as of Jun 2025, the value is 29.00%. The value appears to be improving (decreasing) as expected. It has decreased from 34.00% (Mar 2025) to 29.00%, marking a decrease of 5.00%.
• For Net Profit, as of Jun 2025, the value is 15.00 Cr.. The value appears strong and on an upward trend. It has increased from 11.00 Cr. (Mar 2025) to 15.00 Cr., marking an increase of 4.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 2.29. The value appears strong and on an upward trend. It has increased from 1.76 (Mar 2025) to 2.29, marking an increase of 0.53.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 4:53 am

Balance Sheet

Last Updated: June 16, 2025, 11:44 am

Below is a detailed analysis of the balance sheet data for Manaksia Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 13.00 Cr..
• For Reserves, as of Mar 2025, the value is 559.00 Cr.. The value appears strong and on an upward trend. It has increased from 537.00 Cr. (Mar 2024) to 559.00 Cr., marking an increase of 22.00 Cr..
• For Borrowings, as of Mar 2025, the value is 26.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 74.00 Cr. (Mar 2024) to 26.00 Cr., marking a decrease of 48.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 116.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 97.00 Cr. (Mar 2024) to 116.00 Cr., marking an increase of 19.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 714.00 Cr.. The value appears to be improving (decreasing). It has decreased from 722.00 Cr. (Mar 2024) to 714.00 Cr., marking a decrease of 8.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 48.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 48.00 Cr..
• For CWIP, as of Mar 2025, the value is 6.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 6.00 Cr., marking an increase of 6.00 Cr..
• For Investments, as of Mar 2025, the value is 111.00 Cr.. The value appears to be declining and may need further review. It has decreased from 426.00 Cr. (Mar 2024) to 111.00 Cr., marking a decrease of 315.00 Cr..
• For Other Assets, as of Mar 2025, the value is 549.00 Cr.. The value appears strong and on an upward trend. It has increased from 248.00 Cr. (Mar 2024) to 549.00 Cr., marking an increase of 301.00 Cr..
• For Total Assets, as of Mar 2025, the value is 714.00 Cr.. The value appears to be declining and may need further review. It has decreased from 722.00 Cr. (Mar 2024) to 714.00 Cr., marking a decrease of 8.00 Cr..

Notably, the Reserves (559.00 Cr.) exceed the Borrowings (26.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Manaksia Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 8.54. This value is within the healthy range. It has decreased from 11.53 (Mar 24) to 8.54, marking a decrease of 2.99.
• For Diluted EPS (Rs.), as of Mar 25, the value is 8.54. This value is within the healthy range. It has decreased from 11.53 (Mar 24) to 8.54, marking a decrease of 2.99.
• For Cash EPS (Rs.), as of Mar 25, the value is 9.71. This value is within the healthy range. It has decreased from 13.44 (Mar 24) to 9.71, marking a decrease of 3.73.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 87.31. It has decreased from 88.43 (Mar 24) to 87.31, marking a decrease of 1.12.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 87.31. It has decreased from 88.43 (Mar 24) to 87.31, marking a decrease of 1.12.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 111.55. It has increased from 107.05 (Mar 24) to 111.55, marking an increase of 4.50.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 16.55. This value is within the healthy range. It has decreased from 24.25 (Mar 24) to 16.55, marking a decrease of 7.70.
• For PBIT / Share (Rs.), as of Mar 25, the value is 15.71. This value is within the healthy range. It has decreased from 22.82 (Mar 24) to 15.71, marking a decrease of 7.11.
• For PBT / Share (Rs.), as of Mar 25, the value is 12.94. This value is within the healthy range. It has decreased from 15.88 (Mar 24) to 12.94, marking a decrease of 2.94.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 8.87. This value is within the healthy range. It has decreased from 12.01 (Mar 24) to 8.87, marking a decrease of 3.14.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 8.54. This value is within the healthy range. It has decreased from 11.53 (Mar 24) to 8.54, marking a decrease of 2.99.
• For PBDIT Margin (%), as of Mar 25, the value is 14.83. This value is within the healthy range. It has decreased from 22.65 (Mar 24) to 14.83, marking a decrease of 7.82.
• For PBIT Margin (%), as of Mar 25, the value is 14.08. This value is within the healthy range. It has decreased from 21.31 (Mar 24) to 14.08, marking a decrease of 7.23.
• For PBT Margin (%), as of Mar 25, the value is 11.59. This value is within the healthy range. It has decreased from 14.83 (Mar 24) to 11.59, marking a decrease of 3.24.
• For Net Profit Margin (%), as of Mar 25, the value is 7.95. This value is within the healthy range. It has decreased from 11.21 (Mar 24) to 7.95, marking a decrease of 3.26.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 7.65. This value is below the healthy minimum of 8. It has decreased from 10.76 (Mar 24) to 7.65, marking a decrease of 3.11.
• For Return on Networth / Equity (%), as of Mar 25, the value is 9.78. This value is below the healthy minimum of 15. It has decreased from 13.72 (Mar 24) to 9.78, marking a decrease of 3.94.
• For Return on Capital Employeed (%), as of Mar 25, the value is 16.86. This value is within the healthy range. It has decreased from 25.42 (Mar 24) to 16.86, marking a decrease of 8.56.
• For Return On Assets (%), as of Mar 25, the value is 7.84. This value is within the healthy range. It has decreased from 10.46 (Mar 24) to 7.84, marking a decrease of 2.62.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.04. This value is within the healthy range. It has decreased from 0.13 (Mar 24) to 0.04, marking a decrease of 0.09.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.02. It has increased from 0.66 (Mar 24) to 1.02, marking an increase of 0.36.
• For Current Ratio (X), as of Mar 25, the value is 6.29. This value exceeds the healthy maximum of 3. It has increased from 4.90 (Mar 24) to 6.29, marking an increase of 1.39.
• For Quick Ratio (X), as of Mar 25, the value is 5.37. This value exceeds the healthy maximum of 2. It has increased from 4.39 (Mar 24) to 5.37, marking an increase of 0.98.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 9.02. This value exceeds the healthy maximum of 8. It has increased from 5.24 (Mar 24) to 9.02, marking an increase of 3.78.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 9.30. This value is within the healthy range. It has decreased from 12.93 (Mar 24) to 9.30, marking a decrease of 3.63.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 6.54. This value is within the healthy range. It has decreased from 10.10 (Mar 24) to 6.54, marking a decrease of 3.56.
• For Enterprise Value (Cr.), as of Mar 25, the value is 182.83. It has decreased from 662.00 (Mar 24) to 182.83, marking a decrease of 479.17.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.25. This value is below the healthy minimum of 1. It has decreased from 0.94 (Mar 24) to 0.25, marking a decrease of 0.69.
• For EV / EBITDA (X), as of Mar 25, the value is 1.69. This value is below the healthy minimum of 5. It has decreased from 4.17 (Mar 24) to 1.69, marking a decrease of 2.48.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.52. This value is below the healthy minimum of 1. It has decreased from 0.91 (Mar 24) to 0.52, marking a decrease of 0.39.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Price / BV (X), as of Mar 25, the value is 0.66. This value is below the healthy minimum of 1. It has decreased from 1.17 (Mar 24) to 0.66, marking a decrease of 0.51.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.52. This value is below the healthy minimum of 1. It has decreased from 0.91 (Mar 24) to 0.52, marking a decrease of 0.39.
• For EarningsYield, as of Mar 25, the value is 0.14. This value is below the healthy minimum of 5. It has increased from 0.11 (Mar 24) to 0.14, marking an increase of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness